Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Single Program Access
Antibody Discovery Platform
Heavy Chain Only Antibody
Antibodies
HCAb
Therapeutics
Unlimited Access
Soluble antigen specific VH domains
Limited Access
Murine antibody humanization
Transgenic Mouse
H2L2
Mouse antibody platform
Date founded
2006
Funding rounds raised
Total raised
$3.3M
from 1 investors over 1 rounds
H
Harbour Antibodies raised $3.3M on July 24, 2013
Investors: Atlas Venture